Top 50 Medical Startup Investors in Austria (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
XISTA Science Ventures
VC Fund
|
7 | Austria, France, Slovenia | Seed, Pre-Seed, Series A | Biotechnology, Medical, Software | $511k–$20M |
|
xista science ventures
VC Fund
|
5 | Austria, Slovenia | Seed, Pre-Seed, Series A | Biotechnology, Medical, Software | $511k–$20M |
|
APEX Ventures
VC Fund
|
4 | Germany, United Kingdom, Austria | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Health Care | $511k–$21M |
|
SOSV
VC Fund
|
4 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
eQventure
VC Fund
|
3 | Austria, Switzerland | Seed, Series A | Software, Information Technology, Artificial Intelligence | $549k–$6.6M |
|
tecnet equity
VC Fund
|
3 | Austria | Seed, Series A | Software, SaaS, Biotechnology | $400k–$6M |
|
MassMutual Ventures
VC Fund
|
3 | United States, India, Singapore | Series A, Series B, Seed | Software, Financial Services, Information Technology | $2.5M–$40M |
|
VP Venture Partners
VC Fund
|
2 | Austria, Switzerland | Seed | Medical, Health Diagnostics, Internet | $3M–$3.3M |
|
MIG Capital
VC Fund
|
2 | Germany, France, Austria | Series A, Series B | Biotechnology, Health Care, Therapeutics | $1.6M–$54M |
|
MMC Ventures
VC Fund
|
2 | United Kingdom, United States, France | Seed, Series A, Series B | Software, Artificial Intelligence, Machine Learning | $1.2M–$54M |
|
Johann "Hansi" Hansmann
Angel
|
2 | Austria, United Kingdom, Germany | Seed, Angel, Pre-Seed | Software, Health Care, Fitness | $300k–$4.1M |
|
LANA Ventures
VC Fund
|
2 | Austria, Germany | Seed, Pre-Seed | Health Care, Apps, Medical | $6.5M–$6.6M |
|
bmp Ventures
VC Fund
|
2 | Germany, United States, Austria | Seed, Series A | Software, Information Technology, Manufacturing | $30k–$5.9M |
|
Rene Schneider
Angel
|
2 | Austria | Seed, Series A | Medical, Analytics, Health Diagnostics | |
|
aws Gründungsfonds
VC Fund
|
2 | Austria, Germany, United States | Seed, Series A | Software, SaaS, Information Technology | $1.1M–$12M |
|
Peak Pride
VC Fund
|
2 | Austria, Germany | Seed, Series A, Pre-Seed | Health Care, Medical, Health Diagnostics | $165k–$6.5M |
|
PONTIS Venture Partners Management
VC Fund
|
1 | Austria, Germany | Series A, Series B, Series C | Software, Manufacturing, Information Technology | $4.9M–$6M |
|
Algorithm Ltd
VC Fund
|
1 | Austria | Series A | Medical, Analytics, Health Diagnostics | |
|
Crista Galli Ventures
VC Fund
|
1 | United Kingdom, United States, Sweden | Seed, Pre-Seed, Series A | Health Care, Medical, Wellness | $655k–$14M |
|
MMV Europe & Asia-Pacific
VC Fund
|
1 | Singapore, India, United States | Series A, Seed, Series B | Financial Services, FinTech, Health Care | $2.4M–$65M |
|
Arax Capital Partners
VC Fund
|
1 | Austria | Seed | Biotechnology, Health Care, Medical | |
|
austria Wirtschaftsservice (aws)
VC Fund
|
1 | Austria, Belgium | Seed, Grant, Pre-Seed | Software, SaaS, Information Technology | $44k–$2.7M |
|
RoX Health
VC Fund
|
1 | Germany, Austria | Pre-Seed, Seed | Health Care, Health Diagnostics, Apps | |
|
NEOÏ S.à.r.l
VC Fund
|
1 | Austria | Series A | Medical, Analytics, Health Diagnostics | |
|
Die Brückenköpfe
VC Fund
|
1 | Germany, Austria | Seed, Series A, Pre-Seed | Health Care, Life Science, Therapeutics | $5.5M–$19M |
|
FREE VALLEY HOLDINGS LIMITED
VC Fund
|
1 | Austria | Series A | Medical, Analytics, Health Diagnostics | |
|
Biopart
VC Fund
|
1 | Austria | Series A | Medical, Analytics, Health Diagnostics | |
|
West Asia Investment Partners S.a.r.l.
VC Fund
|
1 | Austria | Series A | Medical, Analytics, Health Diagnostics | |
|
Ascend Capital Partners
VC Fund
|
1 | Finland, Israel, Austria | Series A, Seed | Health Care, Medical Device, Software | $1.5M–$12M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
1 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.3M–$50M |
|
Wellcome Trust
VC Fund
|
1 | United States, United Kingdom, France | Grant, Series C | Biotechnology, Health Care, Medical | $1.3M–$127M |
|
Techno Venture Management
VC Fund
|
1 | United States, Germany, United Kingdom | Series B, Series A | Biotechnology, Health Care, Pharmaceutical | $4.7M–$44M |
|
Gamma Capital Partners
VC Fund
|
1 | Austria, United States, Germany | Series A, Seed | Software, Manufacturing, Information Technology | $406k–$8M |
|
Medicus Ltd
VC Fund
|
1 | Austria | Series A | Medical, Analytics, Health Diagnostics | |
|
FCPG Affi
VC Fund
|
1 | Austria | Medical, Biotechnology, Pharmaceutical | ||
|
Novartis Venture Fund
VC Fund
|
1 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $5.1M–$120M |
|
red-stars.com
VC Fund
|
1 | Austria, Germany | Seed, Series A | Software, Biotechnology, Telecommunications | $1.6M–$4.4M |
|
PUSH VC
VC Fund
|
1 | Austria, Germany, United States | Seed, Series A | Software, Apps, Health Care | $650k–$32M |
|
HBM Partners
VC Fund
|
1 | United States, Germany, Switzerland | Series B, Series C | Biotechnology, Medical, Health Care | $2.5M–$125M |
|
Rafael Vartian
Angel
|
1 | Austria | Series A | Medical, Analytics, Health Diagnostics | |
|
IBG Beteiligungsgesellschaft Sachsen-Anhalt
VC Fund
|
1 | Germany, Austria | Seed, Series A | Software, Electronics, Manufacturing | $1.3M–$5.9M |
|
EMBL Ventures
VC Fund
|
1 | Germany, Austria, Ireland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $3.9M–$70M |
|
redalpine
VC Fund
|
1 | Germany, Switzerland, United Kingdom | Seed, Series A, Series B | Biotechnology, Health Care, Software | |
|
Lead Ventures
VC Fund
|
1 | Hungary, United Kingdom, Croatia | Series A, Seed, Series B | Software, SaaS, Artificial Intelligence | |
|
TBA Network
VC Fund
|
1 | Austria, Italy | Seed | Apps, Medical, mHealth | |
|
GLS Ventures
VC Fund
|
1 | Austria | Series B | Medical, Health Care, Biotechnology | |
|
Santo Holding
VC Fund
|
1 | Germany, Austria | Series B, Series C | Biotechnology, Energy, Medical | |
|
Revere Partners
VC Fund
|
1 | United States, The Netherlands, Austria | Seed, Pre-Seed, Series A | Health Care, Dental, Software | |
|
Tensor Ventures
VC Fund
|
1 | Czech Republic, United States, United Kingdom | Pre-Seed, Seed | Artificial Intelligence, Information Technology, Machine Learning | |
|
i&i Biotech Fund
VC Fund
|
1 | Czech Republic, India, Spain | Seed, Series A | Biotechnology, Health Care, Medical | |
| Access all 93 investors in Austria Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Austria, France, Slovenia
Investor stats
- Total investments: 33
- Round size: Seed $576k–$5.9M; Pre-Seed $511k–$1.4M; Series A $5.2M–$20M
- Lead/follow: 61% lead, 39% follow
Portfolio highlights
- Rivus Batteries — Rivus is a start-up that serves as the commercialization platform for the aqueous organic flow battery technology.
- Factorymaker — Factorymaker designs and analyzes sustainable, cost-efficient industrial layout and building proposals, guiding you through informed decisions at early design stage
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Austria, Slovenia
Investor stats
- Total investments: 22
- Round size: Seed $1.8M–$7.8M; Pre-Seed $511k–$1.4M; Series A $5.2M–$20M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- subdron — subdron turns the seabed from a blind spot into a monitored domain.
- infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
APEX Ventures is a deep-tech and medical-focused venture capital firm.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, Austria
Investor stats
- Total investments: 53
- Round size: Seed $1.3M–$8M; Pre-Seed $511k–$3M; Series A $2.2M–$21M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
- HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
- TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Entrepreneurs for Entrepreneurs
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Austria, Switzerland
Investor stats
- Total investments: 57
- Round size: Seed $549k–$1.2M; Series A $768k–$6.6M
- Lead/follow: 79% lead, 21% follow
Portfolio highlights
- Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
- Respory — Respory provides real-time people-tracking using proprietary radar sensors, all without capturing personal data. Our scalable sensor network, powered by AI-driven algorithms, delivers precise customer journey insights, critical for in-store performance in retail.
- 2nd Cycle — 2nd Cycle creating a cost-effective, fully automated, and scalable solution for modules for a second life cycle.
tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.
Show more...Investment focus
- Industry: Software, SaaS, Biotechnology
- Stage:Seed, Series A
- Geography: Austria
Investor stats
- Total investments: 62
- Round size: Seed $400k–$2.5M; Series A $583k–$6M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — last raise in 2009
Portfolio highlights
- eyeson — eyeson is a leader in cloud-based video conferencing with managed multipoint video processing technology at a scale. Based on its patented single stream technology, eyeson provides API video services to easily integrate video collaboration in business workflows for full customer engagement. eyeson is managing the cloud capacity, scalable videocoding performance and data management for the customer. Based on WebRTC technology, eyeson provides browser-based video meeting integrations on all desktop and mobile devices. eyeson offers B2B focused products used by Forbes 500 companies and named by Gartner as "cool vendor in unified communications."
- Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
- Greenwood-Power — Greenwood-Power is the leading innovator for non-conventional transformers. Let's talk about your individual requirements - CONTACT US TODAY!
MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.
Show more...Investment focus
- Industry: Software, Financial Services, Information Technology
- Stage:Series A, Series B, Seed
- Geography: United States, India, Singapore
Investor stats
- Total investments: 146
- Round size: Seed $2.5M–$9.3M; Series A $4.4M–$23M; Series B $7.5M–$40M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $100M in 2022
Portfolio highlights
- Zylo — You Have Questions About Your Software. We Give You Answers. Discover why Zylo is the leader in enterprise SaaS Management.
- Knowify — Knowify helps trade contractors bid, manage, and invoice commercial and residential jobs on time and on budget, starting at $99/month.
- Acorn Finance — Boost sales and win more jobs by offering fast, affordable financing through Acorn Finance. Simple setup, instant offers, and no dealer fees.
VP Venture Partners is a venture capital firm invests in healthcare companies.
Show more...Investment focus
- Industry: Medical, Health Diagnostics, Internet
- Stage:Seed
- Geography: Austria, Switzerland
Investor stats
- Total investments: 3
- Round size: Seed $3M–$3.3M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
- Moonlight AI — Moonlight AI empowers pathologists and hematologists to make therapeutic decisions backed by genomic insight. Moonlight AI was founded in 2022 and is headquartered in Jura, Switzerland.
- aTension.life — aTension.life is a company focused on advancing the diagnosis and treatment of hypertension through precision medicine. It employs cutting-edge mass spectrometry technology to identify the underlying causes of uncontrolled hypertension using a single blood sample. aTension.life aims to provide personalized diagnostic solutions that enhance patientcare and support laboratories with accurate and reliable tools. The company's mission is to improve the quality of life for hypertensive patients by making advanced diagnostics widely accessible and enabling more effective, individualized therapies.
MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: Germany, France, Austria
Investor stats
- Total investments: 96
- Round size: Series A $2.2M–$40M; Series B $1.6M–$54M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $70M in 2014
Portfolio highlights
- NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
- GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
- Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain
MMC is a venture capital fund investing in early stage, high-growth UK companies. Investing in technology companies at Seed and Series A.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 214
- Round size: Seed $1.2M–$9M; Series A $2.4M–$20M; Series B $6M–$54M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $124M in 2019
Portfolio highlights
- YuLife — Meet YuLife - the all-in-one platform for group insurance, employee benefits, wellbeing, engagement, and global rewards your people love and actually use.
- Atlas Metrics — The single source of truth for your ESG data
- Snowplow — Snowplow gives teams complete flexibility and control over how behavioral data is collected, structured, processed, modeled and stored.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Dr. Johann ‘Hansi’ Hansmann was born in Austria and studied economics in Vienna. He spent the major part of his professional life working as an executive in the pharmaceutical industry in Austria, Germany, UK and Spain. He gathered several years of entrepreneurial experience running successfully his own pharmaceutical company in Spain afterconducting a management buy-out of a big pharmaceutical plant, making an exit in 2003. Since this time he is active as investor and business angel. He currently holds investments with a geographical focus on Austria, Germany, UK and Spain both internet and in the health industry. He led Runtastic, shpock, mysugr and just recently durchblicker and Busuu to extraordinary exits. He was president of the ‘Austrian Angels Investors Association’ until 2021, was awarded 'Best European Early Stage Investor' in 2016 by eban.org and is now based in Vienna and tries to find spare time to ride his mountain bike.
Show more...Investment focus
- Industry: Software, Health Care, Fitness
- Stage:Seed, Angel, Pre-Seed
- Geography: Austria, United Kingdom, Germany
Investor stats
- Total investments: 70
- Round size: Seed $300k–$4.1M; Angel $329k–$603k; Pre-Seed $439k–$2.7M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- fynk — Create, edit, negotiate and sign contracts quickly with fynk. Give your team back valuable time. Test it now for free!
- reebuild — reebuild is the developer of an online application for construction companies designed to automate material procurement and logistics. Their digital infrastructure platform connects construction companies, industry, and trade, enabling clients to build their invoices and environmental data in a secure cloud and take over administrative processes inthe background.
- Viora - visible through confidence — Ada Growth is on a mission to put a mentor in every woman's pocket. We combine AI with microlearning to provide professional growth and development tools for women in the workplace and help companies attract, retain, and grow female talent. Download the Ada App today!The Ada App is a microlearning app that provides 2 minute short formvideos, miniquizzes, action items, and summaries that lead to long-term behavioral changes in the workplace. It also contains a digital mentor that can provide dynamic coaching in the spirit of the Ada App library of content, so that Ada App users have access to casual lessons when they have a few minutes a day as well as immediate feedback for any upcoming situation.Ada Growth serves the B2B enterprise and SME space primarily to companies with over 400 employees. We sell a professional growth / EdTech / L&D solution to HR, Employee Training and DEI administrators. We are vertical agnostic and provide a growth experience for both white collar and blue collar workers. Most EdTech solutions tend to flow to the corporate office layer of an enterprise, where this is a saturation of resources available. Many of our users have not been given professional growth tools purposefully built for them before or made flexible for their lifestyle, unlocking value for both the employee as well as the employer.We are the first enterprise-ready professional EdTech solution built specifically for women.
LANA Ventures is a venture capital firm.
Show more...Investment focus
- Industry: Health Care, Apps, Medical
- Stage:Seed, Pre-Seed
- Geography: Austria, Germany
Investor stats
- Total investments: 3
- Round size: Seed $6.5M–$6.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
- UniteLabs — UniteLabs provides the foundational operating system for AI-driven lab automation in life science. It accelerates scientific discovery by closing the loop with a unified data and automation infrastructure, seamless integration, and intelligent control. Our platform empowers ambitious biotech companies, big pharma, integrators, and hardware vendorsby offering bidirectional connectors for diverse lab equipment, a scalable cloud platform with an open API, and a powerful workflow engine with an integrated compute environment. This allows for the creation of sophisticated, modular workflows, and enables rapid automation development through our Lab-as-Code environment, featuring a dynamic Python SDK and application-specific libraries.
bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Germany, United States, Austria
Investor stats
- Total investments: 119
- Round size: Seed $151k–$3.8M; Series A $30k–$5.9M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
- Solar Materials — SOLAR MATERIALS developed a recycling technology for solar modules, which recovers all raw materials for a circular solar industry.
- Litherm Technologies — Litherm Technologies GmbH is a German deep‑tech startup focused on decarbonizing lime and cement production using fully electric kiln technology.
Rene Schneider
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Seed, Series A
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: Austria, Germany, United States
Investor stats
- Total investments: 85
- Round size: Seed $1.1M–$5.2M; Series A $1.1M–$12M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Upnano — Upnano engages in the manufacture and commercialization of 3D printing systems.
- OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
- vitrealab — Enlighten. Your perspective. Light Engines for AR glasses.
Multi family office investing in proptech, digital health & sustainability
Show more...Investment focus
- Industry: Health Care, Medical, Health Diagnostics
- Stage:Seed, Series A, Pre-Seed
- Geography: Austria, Germany
Investor stats
- Total investments: 10
- Round size: Seed $165k–$658k; Series A $2.2M–$6.5M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
- Kranus Health — Kranus Health is a global provider for Men‘s Health Prescription Digital Therapeutics (PDTs). Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.
- HelloBello — HelloBello offers freshly cooked and cooled delivered human-grade food tailored to each dog’s nutritional needs. HelloBello is a PetTech company with a strong focus on the German speaking markets (for now). HelloBello’s personalized meals are free of any by-products and are portioned, packaged, and delivered directly to your door. By working with aspecialized veterinarian, HelloBello is able to derive each dog’s exact nutritional needs based on a proprietary algorithm. The recipes are made of natural sources like millet and seaweed, instead of heavy use of supplements, which makes it easier for the dog to absorb and get true nutritional benefits.Our credo in German is " ... Frisch. Individuell. Geliefert. - Frischfutter ist einfach besser ..."
PONTIS Capital manages two funds with total commitments of more than EUR 60 million, and is actively investing out of its second fund, PONTIS Growth Capital II (“PGC II”). The focus of PGC II is to invest in small and medium-sized growth companies with Established technology or other competitive advantage Existing proof-of-market in marketswith growth potential,Scalable business models, andHeadquarters in the DACH region (Germany, Austria, Switzerland)
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Series A, Series B, Series C
- Geography: Austria, Germany
Investor stats
- Total investments: 7
- Round size: Series A $4.9M–$6M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- evidanza — evidanza GmbH is a software provider of business intelligence solutions for reporting, planification, OLAP-analysis, risk management, costs calculations, IFRS- and USGAAP-reporting. The company is headquartered in Salching, Germany.
- SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
- GAT Microencapsulation — GAT Microencapsulation is an innovative, highly dynamic technology company and is considered to be one of Europe's leading microencapsulation companies, especially for Functional Food and Agro Generics. GAT's proprietary and globally patented technology for Functional Food ingredients enables the use of sensitive active ingredients suchas Omega-3 in a variety of foods, ensuring maximum stability throughout the production process and long product life.
Investment Company
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Series A
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
Physician-led venture capital investing in TechBio, DeepTech Healthcare, and Digital Health.
Show more...Investment focus
- Industry: Health Care, Medical, Wellness
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Sweden
Investor stats
- Total investments: 36
- Round size: Seed $960k–$8.5M; Pre-Seed $655k–$2.5M; Series A $5.2M–$14M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Jude — Science-backed food supplement that makes you feel empowered, not embarrassed.
- Vitrue Health — At Vitrue Health, our mission is to reduce or eliminate the impact that musculoskeletal health issues have on over 40% of the population using cutting edge technology. We believe that the foundation of successful outcomes in musculoskeletal health, at every stage of the pathway, is accurate assessment. Whether it's a desk worker with early stages of neck pain or a patient having a total knee replacement, Vitrue's technology can help.
- Collective Minds Radiology — Collective Minds develops and delivers a cloud-based collaboration platform for healthcare and research with access to data, human and digital expertise.
MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.
Show more...Investment focus
- Industry: Financial Services, FinTech, Health Care
- Stage:Series A, Seed, Series B
- Geography: Singapore, India, United States
Investor stats
- Total investments: 33
- Round size: Seed $2.4M–$7.5M; Series A $4M–$15M; Series B $20M–$65M
- Lead/follow: 58% lead, 42% follow
- Last fund: May invest from a new fund soon — raised $100M in 2020
Portfolio highlights
- Privyr — Supercharge your sales with instant lead alerts, auto-personalised content, interest tracking, easy follow-ups & lead management. All from your phone, within seconds.
- Fund That Flip — Fund That Flip offers customized lending for real estate investors. Partner with America's fastest-growing direct lender. Better than your hard money lender.
- Biofourmis — Biofourmis partners with risk-bearing organizations and life science companies to provide solutions that help expand the delivery of care to everyone, everywhere.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed
- Geography: Austria
Investor stats
- Total investments: 5
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
- Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
- Calyxha Biotechnologies GmbH — A new perspective on inflammation
The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Grant, Pre-Seed
- Geography: Austria, Belgium
Investor stats
- Total investments: 59
- Round size: Seed $439k–$2.7M; Grant $62k–$603k; Pre-Seed $44k–$1.9M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- Digicust — Extend your existing customs software by adding AI customs agents to automate customs declarations and save time and money.
- Repentium — Repentium serves industrial manufacturers seeking reproducible, cost-efficient 3D printing and engineering-grade plastic parts.
- Another Earth — Another Earth is building an AI-powered simulation and synthetic data platform for Earth Observation. As our planet changes, AI models need scalable, high-quality training data to keep pace. Another Earth provides synthetic data, scenario simulations and predictions required to accelerate AI development, and enable faster, smarterdecision-making—enabling smarter decisions for a more resilient world.
ROX Health is a digital healthcare innovation studio empowering early-stage health startups in oncology, neurology, cardiovascular metabolism, and women's health. We provide expertise, networks, and market access.
Show more...Investment focus
- Industry: Health Care, Health Diagnostics, Apps
- Stage:Pre-Seed, Seed
- Geography: Germany, Austria
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
- Halitus — Laser Technology x Gas Dynamics Analysis x Machine Learning.
- MindAhead — Digital Health, Med Tech, Brain Health
Investment Company
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Series A
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
Die Brückenköpfe is a management consulting and investing firm focused on the German healthcare market.
Show more...Investment focus
- Industry: Health Care, Life Science, Therapeutics
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Austria
Investor stats
- Total investments: 7
- Round size: Series A $5.5M–$19M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- anvajo — Lab diagnostics for everyone, everywhere. Understanding fluids through light and algorithms
- Skinuvita — Skinuvita specializes in developing digital home treatment solutions for chronic autoimmune skin diseases such as psoriasis, atopic dermatitis, and vitiligo. Utilizing specific wavelengths of UV light (311nm) that have a calming effect on skin's immune cells responsible for inflammation, Skinuvita's approach to phototherapy aims toimprove the quality of life for patients. The company offers a patient app that guides users through therapy sessions and analyzes responses for dosage optimization, alongside tools for dermatologists to monitor treatment progress. This innovative approach allows for effective management of skin conditions from the comfort of one's home.
- Recare — Recare developed a software platform for discharge management and supply control in hospitals and other medical facilities. With its B2B marketplace, Recare is trying to end the paperwork in the German healthcare system.
Investment Company
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Series A
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
Biopart
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Series A
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
Investment Company
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Series A
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
Founded by two Wall Street professionals in 2002 with the goal of making companies successful by helping them raise capital and improve their management standards. This was done by taking an active role in running these companies (at the Board level and operationally) and helping to secure strategic partnerships.Over USD 100 million in assetsgenerated from successful investments in China, and more recently in Europe. All invested funds come from our partners; no 3rd party money is managed. Since the partners are investing their own capital, they are dedicated to making their investments successful.Led by Monita Mo, one of the founders and a serial entrepreneur. Our partners have decades of experience across a wide range of industries and geographical regions. All investment partners have done business in Asia and bring an extensive network of contacts for our investments. Additionally, they have started, managed, and sold businesses and understand the challenges involved.See the need to share more developed technology to other markets, especially in China, where growth opportunities may be greater. That is why we are currently focusing on companies in Europe and other developed markets that have unique technologies that can be commercialized in their home markets, Asia, and the US.
Show more...Investment focus
- Industry: Health Care, Medical Device, Software
- Stage:Series A, Seed
- Geography: Finland, Israel, Austria
Investor stats
- Total investments: 18
- Round size: Seed $1.5M–$9.3M; Series A $2.2M–$12M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Pionix — open source software as a service for charging stations / e-mobility
- piur imaging — PIUR´s tomographic ultrasound solutions turn any standard ultrasound system into a tomographic 3D imaging device, bridging the gap between 2D ultrasound and regular tomographic imaging modalities. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated and stored as quantifiable volumes, enabling true AIpost-processing for efficient diagnostics. Current focus is on thyroid imaging where AI algorithms allow doctors a fast and objective analysis and classification of thyroid nodules.
- Nanoflex Robotics — Nanoflex Robotics develops a soft robotic system that precisely inserts specially made guidewires and catheters deep into the brain. The company provides patented magnetic navigation technology but also the necessary surgical devices. Nanoflex Robotics was established in May, 2021 in Zurich, Switzerland.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 98
- Round size: Seed $1.3M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- ArrePath — ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
- Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.
- Centauri Therapeutics — At Centauri we seek to tackle life-threatening infectious diseases in the most vulnerable patients.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Grant, Series C
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 121
- Round size: Grant $1.3M–$8.9M; Series C $10M–$127M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $319M in 2018
Portfolio highlights
- System — System is a free, open, and living public resource that aims to explain how anything in the world is connected to everything else.
- Lario Therapeutics — Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.
- Ineffable Intelligence — Ineffable Intelligence develops machine learning systems that learn through interaction and experience. The company works on reinforcement learning approaches that allow models to improve by trial and error rather than relying on large human-generated datasets. Its core work centers on building a “superlearner,” a system designed to generateknowledge and skills by engaging with simulated or real environments.The organization develops algorithms and computational frameworks that support autonomous learning, experimentation, and decision-making processes. Its efforts involve designing AI models that can adapt, refine behavior, and solve complex problems through continuous feedback loops. The company’s research aims to expand how AI systems acquire knowledge and apply it across different domains.
Techno Venture Management is a venture capital and private equity firm focused on healthcare industry.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 99
- Round size: Series A $4.7M–$22M; Series B $5.2M–$44M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Streaming21 — Streaming21 is a solution provider of seamless on-demand and IP broadcasting service platform for connected digital home.
- Helomics — Helomics® is a comprehensive personalized healthcare company, bringing the next generation of diagnostics to the oncology field. Helomics is dedicated to improving patient outcomes by providing a personalized comprehensive tumor profile utilizing a proprietary set of laboratory platforms that leverage both tissue-based live and fixed cellular basedanalysis allowing physicians to characterize malignant tumors on a personalized basis. Helomics’ novel molecular and cellular markers and bioinformatics services support treatment decisions by providing vital information based on the specific biological processes of each individual’s cancer.
- Precision Therapeutics — Precision Therapeutics is a pharmaceutical research and development business that develops personalized cancer treatments for patients.
gcp gamma capital partners is an independent Venture Capital investment firm, focused on financing dynamic technology companies in Austria, Germany, Switzerland and CEE countries.They seek to achieve superior returns by finding assets with substantial potential in their regional and sectoral focus areas, before they appear on the radar screenof mainstream players in terms of stage and/or initial investment size.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Series A, Seed
- Geography: Austria, United States, Germany
Investor stats
- Total investments: 29
- Round size: Seed $406k–$636k; Series A $1.3M–$8M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Icomasoft — Icomasoft ag is a Swiss pioneer of agent-less software solutions providing unprecedented transparency across your virtual and physical IT infrastructure in heterogeneous datacenters.IcomasoftÂ:registered: software solutions collect essential information for mission-critical and business-critical decisions and provide simplified, automated tasksthat support administrators, IT managers and Executives to easily and confidently analyze, plan and optimize their IT capacity. icomasoftÂ:registered: software solutions are vital for your datacenter clarity.
- Henn GmbH & Co KG — Henn GmbH & Co KG develops and commercializes rapid connecting systems for hoses in automotive engine blocks.
- CNSystems Medizintechnik — CNSystems Medizintechnik sells, manufactures, and develops equipment for non-invasive, continuous monitoring of blood pressure and other essential vital parameters. The company was founded in May 1998 as a spin-off from the Medical University and University of Technology Graz, Austria.
Investor
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Series A
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
FCPG Affi
Show more...Investment focus
- Industry: Medical, Biotechnology, Pharmaceutical
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 213
- Round size: Series A $5.1M–$81M; Series B $11M–$120M; Series C $9M–$75M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $200M in 2009
Portfolio highlights
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Bionano Genomics — Discover how Bionano is striving to elevate health and wellness for all through optical genome mapping (OGM) solutions that transform the way the world sees the genome.
- LOQUS23 THERAPEUTICS — LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease and other triplet repeat diseases.
We back B2B software and life-sciences companies with limitless scalability.
Show more...Investment focus
- Industry: Software, Biotechnology, Telecommunications
- Stage:Seed, Series A
- Geography: Austria, Germany
Investor stats
- Total investments: 8
- Round size: Seed $1.6M–$4.4M
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- Txture — End-To-End Cloud Transformation Platform
- HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
- MAVOCO — We create a carrier-grade software for IoT champions, trusted by tier-1 Mobile network operators.
| Investments that move industries
Show more...Investment focus
- Industry: Software, Apps, Health Care
- Stage:Seed, Series A
- Geography: Austria, Germany, United States
Investor stats
- Total investments: 39
- Round size: Seed $650k–$8.1M; Series A $5M–$32M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Gustav — Modern staffing teams use Gustav's VMS to source talent from trusted sub-vendors. Fast, secure, and compliant!
- raicoon — SaaS solution for autonomous operations of renewable energy
- Valutico — Valutico is the world‘s leading provider of web-based company valuation tools.Started in 2014 by a team of enthusiastic Corporate Finance professionals and web developers, the concept was born out of frustration with the status-quo in Corporate Finance practice: That professional company valuations used to be the domain of only the mostsophisticated of investors.At Valutico, it has been their mission from the outset to offer cutting-edge valuation tools to a much wider audience. Today they empower everybody to perform company valuations that meet and exceed the standards of even the leading investment banks and advisory firms.The company today is headquartered in Vienna/Austria and has an additional office in Frankfurt/Germany.
HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series B, Series C
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 41
- Round size: Series B $7.7M–$125M; Series C $2.5M–$113M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $105M in 2012
Portfolio highlights
- Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
- AtaiBeckley — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
- Mineralys Therapeutics — Evolving science is revealing the importance of aldosterone in cardio-renal-metabolic diseases.We are focused on improving outcomes for people managing hypertension, CKD and related diseases that are driven by dysregulated aldosterone. About Aldosterone
Rafael Vartian
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Series A
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!IBG Beteiligungsgesellschaft Sachsen-Anhalt is a venture capital firm makes investments in territories such as Germany and Denmark.
Show more...Investment focus
- Industry: Software, Electronics, Manufacturing
- Stage:Seed, Series A
- Geography: Germany, Austria
Investor stats
- Total investments: 15
- Round size: Seed $1.3M–$3M; Series A $4.4M–$5.9M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- RAYDIAX — We are Raydiax.Interventional only.Our goal is to reinvent computer tomography that is focussed on treatment.
- Solar Materials — SOLAR MATERIALS developed a recycling technology for solar modules, which recovers all raw materials for a circular solar industry.
- PerioTrap Pharmaceuticals GmbH — PerioTrap is an early stage biopharmaceutical company that aims to eradicate the root cause of periodontitis
EMBL Ventures invest throughout Europe with the aim to build companies that create significant commercial opportunities based on new therapeutic treatment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: Germany, Austria, Ireland
Investor stats
- Total investments: 11
- Round size: Series A $3.9M–$15M; Series B $20M–$70M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Arsanis — Arsanis is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. A deep understanding of the pathogenesis of infection, paired with access to some of the most advanced mAb discovery techniques and platforms available today, has positioned Arsanis to build andadvance a pipeline of novel mAbs with multiple mechanisms of action and high potency against their intended targets.The company’s lead clinical program, ASN100, is aimed at serious Staphylococcus aureus infections and is being evaluated in Phase 2 clinical trial for the prevention of S. aureus pneumonia in high-risk, mechanically ventilated patients. In addition to ASN100, its preclinical pipeline is comprised of mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus.Arsanis is a U.S. company headquartered in Waltham, Massachusetts, with European research and preclinical development operations headquartered in Vienna, Austria (Arsanis Biosciences GmbH).
- Topas Therapeutics — Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet need, including autoimmune diseases, allergies and anti-drug antibodies. The Topas Particle Conjugates technology platform induces antigen-specific immune tolerance by harnessing the liver’s naturalimmunology capabilities. The Company has several proprietary programs; lead product candidate TPM203 has recently entered clinical testing for pemphigus vulgaris, an orphan disease. Other programs are in anti-drug antibodies, celiac disease, Type 1 diabetes, as well as a multiple sclerosis program that is available for partnering.Topas has a research and option agreement with Eli Lilly and Company focused on antigen-specific tolerance induction and a multi-year agreement with Boehringer Ingelheim to collaborate in the field of anti-drug antibodies.Topas’ investors include: Epidarex Capital, Gimv, EMBL Ventures, Evotec and Boehringer Ingelheim Venture Fund.
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
redalpine is a thesis-driven vc with deep expertise in software and science. since 2006. we believe in the power of big ideas and in empowering game changers. we don't just invest, we co-create a better tomorrow. together with you.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 167
- Lead/follow: no public data
Portfolio highlights
- Inkitt — Publish stories online, join our author subscription program, and read books online for free. Join the Inkitt community for writers and readers today.
- Donut — Donut helps people discover new ways to build wealth, by providing the easiest and most trusted way to save & earn high yield with DeFi. Donut was founded in 2018 and is dual headquartered in Los Angeles and Berlin.
- Umiami — Umiami Technologies is a leader in plant-based meat. Our proprietary technology allows us to create clean-label and incredibly tasty foods.
Lead Ventures is a Budapest-based venture capital firm, specialist of financing scale-ups in Central Europe. Its mission is to support the region’s most promising ventures with capital, experience and a wide-ranging professional network, enabling them to transform their industry with innovation. Lead Ventures provides equity financing tocompanies in their scale-up phase, the typical ticket size is between EUR 2-10 million. Lead Ventures is searching for dynamic teams with a unique story, outstanding growth potential and solutions tested and validated by the market. The firm seeks to invest in companies operating in the mobility, energy and sustainability as well as b2b services and software sectors, however, Lead Ventures is open to support teams active in other areas as well.Lead Ventures has EUR 200 million under management invested by MOL, the most successful energy company in CEE, and two financial institutions specialised in supporting the startup ecosystem - the Hungarian Development Bank (MFB) and Eximbank.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Hungary, United Kingdom, Croatia
Investor stats
- Total investments: 27
- Lead/follow: no public data
Portfolio highlights
- Oxla — Meet Oxla, the world's fastest-distributed database, designed to handle large amounts of data with ease.
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
- RedTrack.io — RedTrack.io offers real-time access to your media buying KPIs/data: ad tracking, impressions, clicks, conversions across multiple channels & 30 data points.
TBA Network provides risk capital, entrepreneurial expertise, and valuable network support to ambitious founders. TBA objective is to support innovative ideas and contribute to the global expansion of early-stage startups, laying the groundwork for future entrepreneurs.
Show more...Investment focus
- Industry: Apps, Medical, mHealth
- Stage:Seed
- Geography: Austria, Italy
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
- Tree.ly — Tree.ly does climate protection through the projects in European forests through its SaaS platform and hyperlocal CO2-credits.
- ALLSIDES — Covision Media specializes in creating high-quality, relightable 3D models using their industrial 3D scanners. These scanners capture detailed surface information and PBR textures, and are designed for easy integration into virtual environments.
GLS Ventures
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series B
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nabriva Therapeutics — MPOMM Adalah link resmi berlisensi agen mpo slot paling gacor hari ini dengan pilihan bermain di server slot anti rungkat terjamin kemenangan jackpot maxwin menang berapapun akan di bayar lunas
Santo Holding is a Zurich-based investment firm funding biotechnology, pharmaceutical, life sciences, and healthcare companies.
Show more...Investment focus
- Industry: Biotechnology, Energy, Medical
- Stage:Series B, Series C
- Geography: Germany, Austria
Investor stats
- Total investments: 6
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
- SuppreMol — SuppreMol is a privately held biotechnology company that pioneers a novel approach for the treatment of autoimmune diseases which could lead to the cure of these disorders instead of merely treating their symptoms.
- Efficient Energy — Efficient Energy GmbH is an innovative manufacturer and system supplier of environmentally friendly refrigeration technology, based in Feldkirchen near Munich, Germany. The company developed the Bluezero-technology, which uses water as a refrigerant and and thereby entirely avoids fluorinated refrigerants (HFCs). Efficient Energy helps itscustomers overcome the increasing regulatory challenges of refrigeration technology, and offers them long-term, sustainable solutions with its eChiller model range. The eChiller chilled water units are ideally suited for process cooling, machine cooling and the cooling of technical equipment and data centres and provide cooling capacities from 35 kW to 120 kW, depending on the model. With its outstanding cost efficiency and low CO2 footprint, companies benefit on many fronts. The pioneering technology has also been noticed by politics and the media, and has received multiple awards for the eChiller. These include among others the European Business Award for the Environment 2018/2019 from the European Comission and the Red Herring Europe Top 100 in 2020.
Identifying opportunities for investors and providing capital for cutting-edge innovations in the oral and systemic health sectors.
Show more...Investment focus
- Industry: Health Care, Dental, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, The Netherlands, Austria
Investor stats
- Total investments: 13
- Lead/follow: no public data
Portfolio highlights
- Odne — Curing with light
- Peerlogic — Peerlogic is the first conversational intelligence platform built for dental offices. The analytics platform provides detailed conversational insights between the practice and the patient. Conversational analytics, also known as call analytics, is the process of analyzing data points captured from human speech. It helps to identify trends,predict revenue outcomes, and provide best practices. The result is actionable intelligence that improves the dental practice’s bottom line. Conversational analytics can be used to adjust business strategy. Data provides the "why" behind what's working, what's not. By understanding the "why" practice owners are empowered with data-driven information that can be used to adjust business goals, objectives and tactics.
- OrthoPulse — OrthoPulse is a medical device manufacturer that produces dental care equipment, treatment control apps, and photo biomodulation solutions.
New generation venture capital investing into combinatorial technologies
Show more...Investment focus
- Industry: Artificial Intelligence, Information Technology, Machine Learning
- Stage:Pre-Seed, Seed
- Geography: Czech Republic, United States, United Kingdom
Investor stats
- Total investments: 19
- Lead/follow: no public data
Portfolio highlights
- Wultra — Wultra helps the leading banks and fintech companies to secure their digital systems and bring trust to the customer journeys. Our security-related software technologies cover the whole digital banking application stack, be it on the web or mobile platforms.
- Openvibe — Interact With Anyone On The Open Internet. All Decentralised Social Networks, Single Timeline.
- Edmund — Edmund is an enterprise level system that interconnects all manufacturing technologies, providing a comprehensive view of entire factory.
We are i&i Biotech Fund, partners of outstanding founders on their path to global success. We invest in innovative early stage Life Sciences startups.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: Czech Republic, India, Spain
Investor stats
- Total investments: 10
- Lead/follow: no public data
Portfolio highlights
- Antiverse — Designing biologics for 100 challenging targets
- Captain T Cell — Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates.
- Casinvent Pharma — Casinvent Pharma develops new therapeutic options for the treatment of selected malignancies.
Medical Investor funding in Austria at a glance
Stats across 62 deals from 93 investors.
Access all 93 investors in Austria Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Investors in Austria investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 93 investors investing in Austria Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!